NovoCure’s (NVCR) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of NovoCure (NASDAQ:NVCR – Free Report) in a research report released on Thursday,Benzinga reports. They currently have a $30.00 price objective on the medical equipment provider’s stock. Several other research firms have also recently weighed in on NVCR. Wedbush reaffirmed an “outperform” rating and issued a $24.00 […]
More Stories
Cahill Financial Advisors Inc. Purchases 50,375 Shares of Dimensional World ex U.S. Core Equity 2 ETF (NYSEARCA:DFAX)
Cahill Financial Advisors Inc. increased its position in shares of Dimensional World ex U.S. Core Equity 2 ETF (NYSEARCA:DFAX –...
Arch Capital Group Ltd. (NASDAQ:ACGL) Shares Acquired by Hartford Funds Management Co LLC
Hartford Funds Management Co LLC grew its stake in Arch Capital Group Ltd. (NASDAQ:ACGL – Free Report) by 4.1% in...
Cahill Financial Advisors Inc. Purchases 2,332 Shares of Dimensional US Core Equity Market ETF (NYSEARCA:DFAU)
Cahill Financial Advisors Inc. lifted its holdings in Dimensional US Core Equity Market ETF (NYSEARCA:DFAU – Free Report) by 4.6%...
Marco Investment Management LLC Raises Stock Holdings in STMicroelectronics (NYSE:STM)
Marco Investment Management LLC raised its position in shares of STMicroelectronics (NYSE:STM – Free Report) by 12.0% in the 3rd...
CVS Health Co. (NYSE:CVS) Stake Reduced by Marco Investment Management LLC
Marco Investment Management LLC trimmed its stake in CVS Health Co. (NYSE:CVS – Free Report) by 2.3% during the third...
iShares Core S&P Mid-Cap ETF (NYSEARCA:IJH) Shares Sold by StoneX Group Inc.
StoneX Group Inc. lessened its holdings in shares of iShares Core S&P Mid-Cap ETF (NYSEARCA:IJH – Free Report) by 0.8%...